ORKA 8-K 2026-10-26

Oruka Therapeutics, Inc. (ORKA) 8-K dated 2026-10-26 — accession 0001213900-26-112281. This URL is the filing, not the ORKA hub.

Oruka Therapeutics, Inc. (ORKA) is a biotechnology company listed on NASDAQ.

Oruka Therapeutics, Inc. filed a 8-K on 2026-10-26. Accession 0001213900-26-112281.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ORKA revenue for 2023-12-31 was $0. Net income was -$5.3M. ORKA currently screens at market cap $4.27B.

Not investment advice. The ORKA SEC hub lists recent forms. The stock page is the research view.